Endpoints News 生物医药· Kyle LaHucik·· 2026-10-15AI 评分23
Paul Stoffels 拟重振 Galapagos 细胞疗法
Paul Stoffels to bring Galapagos’ cell therapies back to life
AI 导读
Paul Stoffels 未放弃其在 Galapagos 的细胞疗法计划,并拟推动其重振。Galapagos 是比利时药物开发商,他曾以 CEO 身份尝试推动其转型。
正文
Paul Stoffels isn’t giving up on the cell therapy plans he had at Galapagos, the Belgian drug developer that he tried turning around as CEO …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news